W
e previously reported that human adrenal cortices frequently contain subcapsular aldosterone-producing cell clusters (APCCs) (1), which are indistinguishable using hematoxylin-eosin staining (H&E) because they consist of zona glomerulosa-like cells and inner zona fasciculata (zF)-like cells. APCCs are approximately 0.2-1 mm in length and strongly express aldosterone synthase (CYP11B2), but not steroid 11␤-hydroxylase (CYP11B1; cortisol synthesizing enzyme). Aldosterone-producing adenomas (APAs) consist of heterogeneous tumor cells expressing either CYP11B2 or CYP11B1 (1, 2) . Thus, APCCs and APAs are distinct in their cellular arrangements, sizes, and enzyme expression profiles.
Previous studies demonstrated that APAs frequently harbor a heterozygous somatic mutation in one of the four ion channel/pump genes: KCNJ5, ATP1A1, ATP2B3, and CACNA1D (3) (4) (5) (6) . These mutations are considered to cause autonomous aldosterone production by altering intracellular calcium homeostasis. Using next-generation sequencing (NGS) technology, Nishimoto et al (7) recently showed that APCCs carry some APA-associated mutations, which supports APCCs being pathological structures that produce aldosterone autonomously and origins of APAs.
We herein report cases of primary aldosteronism (PA) due to unilateral multiple (adrenocortical micro-) nodules (UMNs) (8) , in which nodules presented novel types of aldosterone-producing lesions. Histology, a steroidogenic enzyme expression pattern, and the distribution of mutations in these lesions suggested that they are possible APCC-to-APA transitional lesions (pAATLs; a tentative term used in this manuscript).
Subjects and Methods
Detailed clinical courses of the cases and methods are available in the Supplemental Data and Methods, respectively. Briefly, two unilateral PA patients were adrenalectomized according to the PA practice guidelines (9, 10) . In case 2, superselective adrenal venous sampling was performed to identify aldosterone production abilities of adrenal segments (Supplemental Figure 1) . Formalin-fixed paraffin-embedded (FFPE) tissues were used for histological and immunohistochemical examinations as well as the preparation of RNA and genomic DNA (gDNA). These RNAs were subjected to quantitative real-time PCR for CYP11B2 mRNA level (CYP11B2-qPCR) to verify successful sample collection. The corresponding gDNAs were then used in NGS mutation analyses. This study was approved by the relevant Institutional Review Boards (see Supplemental Methods).
Discussion

Case 1
H&E staining of the case 1 adrenal showed UMN ( Figure 1A ). Double-immunohistochemical staining for CYP11B2 and CYP11B1 revealed that some of these nodules were positive for CYP11B2 (blue arrowheads in Figure 1, A and B) , whereas the others were negative for CYP11B2 and CYP11B1 (black arrowheads in Figure 1 Serial sections prepared from FFPE specimens collected from cases 1 and 2 (A-J and K-P, respectively) were examined histologically and immunohistochemically. Pairs of serially sectioned slides were stained with H&E (A, C, G, K, and M) as well as double-immunohistochemistry for CYP11B2 (blue-stained) and CYP11B1 (brown-stained) (B, D, H, L, and N). Blue arrowheads indicate pAATLs. The dashed-line boxes in panels A and B indicate the APCC portion of pAATLs. Black arrowheads indicate a DNN (negative for CYP11B2 and CYP11B1). These pairs were obtained from different paraffin blocks (three blocks from case 1 and two blocks from case 2). By referring to these H&E-and CYP11B2/CYP11B1-stained sections, macrodissection was performed from serial sections of these stained sections (E, F, I, J, O, P). The numbers in these macrodissected sections corresponded to the DNA/RNA numbers in Table 1 There was no apparent border between these portions. Thus, the case 1 adrenal showed a novel type of PA pathology harboring CYP11B2-positive nodules with the hybrid characteristics of APCC and APA, which may be pAATL. APA-associated mutations in case 1 nodules were initially examined in a pair of freshly frozen tissues from a nodular lesion (suspected aldosterone-producing lesion [sAPL] 1) and adjacent normal tissues (control 1) (Supplemental Methods). Successful sampling was confirmed by CYP11B2-qPCR of the RNA samples (Table 1) . Sanger sequencing of sAPL 1-gDNA revealed the presence of the reported KCNJ5 (potassium inwardly-rectifying channel, subfamily J, member 5) mutation (p.Gly151Arg) (Supplemental Figure 2 ). We subsequently performed PCR amplification of gDNAs from sAPL 1 and control 1 using the novel primer mix APA_v13 designed to amplify 12 genomic regions covering the reported APA-associated mutation sites (Supplemental Table 1 ). NGS of these amplicons detected the same KCNJ5 mutation with a frequency of 32.5% in sAPL 1 (Table 1 and Supplemental Tables 2 and   3 ). It is important to note that if all cells have a heterozygous mutation, the frequency of the mutation is expected to be 50% because only one of the two alleles is mutated. Overall, NGS using APA_v13 was proven to be useful for detecting APA-associated mutations in frozen tissues.
The same NGS approach was applied to pAATL tissues macrodissected from FFPE sections. We were able to separately collect enriched samples from APCC-like and mAPA-like portions in two large pAATLs (pAATLs 3 and 4; Figure 1, E, F, I , and J). The samples collected included zF as control 2, pAATLs 2-4, and DNNs 1-2 (Table 1 and Supplemental Figures 3-5) . Successful sampling was confirmed by CYP11B2-qPCR of the RNA samples (Table 1) . Although Sanger sequence confirmation was unavailable (Supplemental Methods), we detected an average of 17.7 Ϯ 9.0 (mean Ϯ SD) called variants in these FFPE samples before any filtering (Supplemental Table 3 ).
The mAPA-like portion of pAATL 3 carried a KCNJ5 mutation (p.Gly151Arg) with a frequency of 40.0%, whereas its APCC-like portion did not. Although the amino acid change in the mutation was the same as that in sAPL 1, the base changes were different (GϾC vs GϾA), Abbreviation: N.A., not available. DNA and RNA were isolated from the fresh-frozen and FFPE tissues of cases 1 and 2. RNA was used in CYP11B2-qPCR for the confirmation of sample collection. CYP11B2 levels were shown by fold changes from control samples (control 1 for sAPL 1, control 2 for pAATLs 2-4 and DNN 1, and control 3 for pAATLs 5-7). Libraries were prepared from DNA and were used for NGS, the results of which are shown in Table 1 Table 3 . a The sequencing result of the borders of APCC-like and mAPA-like areas did not show these variants, and this may have been due to a low read count (only four reads on chr1:116932267 to chr1:116932286, in which high-confidence somatic nonsynonymous variants were detected in DNA 26 and 27, Supplemental Table 3 , and Supplemental Figure 4 ). b Control 3 showed 100% single nucleotide variants in ATP2B3 (c.1198CϾT: p.Arg400Trp); however, we considered the result to be an artifact because the CϾT sequence artifact frequently occurs in FFPE samples (11) .
indicating that sAPL 1 and pAATL 3 had different origins. Because only the mAPA-like portion had the mutation, it may have played a role in the transition of the APCC-like histology to the mAPA-like histology. The APCC-like and APA-like portions of pAATL 4 carried both a novel ATP1A1 deletion (p.Ile322_Ile325del) and substitution (p.Ile327Ser), most of which were identified on the same reads on the Integrative Genomics Viewer (Supplemental Figure 6 ), suggesting that these mutations occurred in a single cell. DNNs carried the ATP1A1 (p.Glu123Lys in DNN 1 and p.Leu324Phe in DNN 2) and ATP2B3 (p.Cys406Ter in DNN 2) variants; however, CYP11B2 mRNA levels were very low in these DNNs (Table 1) . Overall, we detected mutations/deletion in three of the four pAATLs (75%) and in both DNNs (DNNs 1 and 2), in which the mutation distribution of pAATL 3 implied a connection between mutagenesis and mAPA development.
Case 2
The extracted case 2 adrenal showed an almost normal histology, except for several nodular hyperplasia ( Figure  1K ). CYP11B2 immunohistochemistry showed UMN (blue arrowheads in Figure 1L ), the nodules of which were 2-3 mm in length. Similar to case 1, these lesions consisted of APCC-like and mAPA-like portions, suggesting that these lesions were pAATLs ( Figure 1N ).
Five DNA samples purified from case 2 FFPE tissues, which included separate APCC-like and mAPA-like portions from pAATL 7 and zF as control 3, were analyzed by NGS after CYP11B2-qPCR confirmation (Table 1 ; Figure  1 , O and P; and Supplemental Figures 7 and 8) . The results in pAATL 7 showed that the mAPA-like portion harbored a novel ATP1A1 mutation (p.Leu337Met), whereas its APCC portion did not. Thus, similar to the mutation in pAATL 3 of case 1, the ATP1A1 mutation may be involved in the development of the mAPA-like portion from its APCC-like portion. Overall, we found that the case 2 adrenal also had an independent mutation in one of the three pAATLs (33.3%), and the mutation localization in pAATL 7 implied the generation of mAPA from APCC.
Conclusions
We herein described novel pAATLs in UMN patients, in which a single pAATL harbored continuous APCC-and mAPA-like histological appearances. Furthermore, in two of the three large pAATLs, APA-associated mutations were detected in the mAPA-like portions, but not in the APCC-like portions. Hence, although further investigations are needed, these results suggest that an mAPA-like portion arises from an existing APCC due to the introduction of mutation(s).
